David Gallego Ortega

A/Prof

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Gallego Ortega is an Associate Professor at the University of Technology Sydney, Australia. His research interests encompass the intersection of oncology, immunology, and microfluidics, particularly focusing on trophoblast differentiation, liquid biopsy technologies for cancer, and the roles of immune cells in tumor progression. Recent publications explore various aspects of cancer biology, including the tumor-killing potential of neutrophils and the influence of the tumor microenvironment on disease progression.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (17)

Christopher Ormandy

University of New South Wales

AUSTRALIA

David Gallego Ortega

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Matrix directs trophoblast differentiation in a bioprinted organoid model of early placental development

Challenges in blood fractionation for cancer liquid biopsy: how can microfluidics assist?

EZHIP’s role in diffuse midline glioma: echoes of oncohistones?

Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease.

Rapid metabolomic screening of cancer cells via high-throughput static droplet microfluidics.

Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy.

A Method for Rapid, Quantitative Evaluation of Particle Sorting in Microfluidics Using Basic Cytometry Equipment

Pleiotrophin drives a prometastatic immune niche in breast cancer.

Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis

Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing

Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.

Disentangling single-cell omics representation with a power spectral density-based feature extraction

Collaborators (17)

Christopher Ormandy

Fabio Zanini

MAJID EBRAHIMI WARKIANI

Cheryl Lewis

Martijn Nawijn

Claire Richards

Samantha Oakes

Matthew Dun

Harry J.M. Groen

Marcel Schmidt

Fatemeh Vafaee

Rolf A. Brekken

Richard Kim

Wataru Fujii

Amelia Parker

Bernadette Saunders

Brooke Pereira

Make your next move.